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Abstract SHANK3 is a scaffolding protein that binds to var-
ious synaptic proteins at the postsynaptic density (PSD) of
excitatory glutamatergic synapses. SHANK3 is not only
strongly implicated in autism spectrum disorders (ASD) but
also plays a critical role in human Phelan-McDermid syn-
drome (22q13.3 deletion syndrome). Accumulated experi-
mental evidence demonstrates that the zebrafish model system
is useful for studying the functions of ASD-related gene dur-
ing early development. However, many basic features of
shank3 transcript expression in zebrafish remain poorly un-
derstood. Here, we investigated temporal, spatial, and
isoform-specific expression patterns of shank3 during
zebrafish development on the basis of previous researches
and the differential effects of each shank3 transcript expres-
sion after exposure to valproic acid (VPA), an ASD-associated
drug. At first, we observed that both shank3a and shank3b
were barely expressed at very early ages (before 24 h post-
fertilization (hpf)), whereas their expression levels were in-
creased and mainly enriched in the nervous system after
24 hpf. Secondly, all of the six shank3 transcripts gradually
increased during the first 7 hpf and then decreased.
Subsequently, they exhibited a second increasing peak be-
tween 1 month post-fertilization (mpf) and adulthood.
Thirdly, VPA treatment affected the isoform-specific expres-
sion of zebrafish shank3. In particular, the mRNA expression
levels of those isoforms that contain a SAM domain were
significantly increased, whereas the mRNA expression level
of those which contained an ANK domain but without a SAM
domain was decreased. To conclude, our findings support the
molecular diversity of shank3 in zebrafish and provide a mo-
lecular framework to understand the isoform-specific function
of shank3 in zebrafish.
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Introduction
Synaptogenesis is a key process that occurs during brain circuitry
development, and inappropriate synapse formation or structure is
thought to underlie a variety of neurodevelopmental disorders
(van Spronsen and Hoogenraad, 2010; Guo et al., 2015).
SHANK3 [SH3 and multiple ankyrin (ANK) repeat domain 3],
as a member of the highly conserved SHANK/ProSAP family, is
a major scaffolding protein that is enriched at the PSD of excit-
atory synapses (Grabrucker et al., 2011; Verpelli et al., 2011;
Boccuto et al., 2013). Accumulating human genetic evidence
supports a strong causal relationship between molecular defects
in the SHANK3 gene and ASD, which is a heritable, debilitating
neurodevelopmental disorder (Grzadzinski et al., 2013;
McGuinness and Johnson, 2013; Wang et al., 2014). Moreover,
recent studies using neuronal cell cultures (Verpelli et al., 2011;
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Durand et al., 2012) and mouse models (Peca et al., 2011; Yang
et al., 2012; Jiang and Ehlers, 2013) have demonstrated critical
roles for SHANK3 in synaptic function, social interaction and
social communication, thus providing a functional link between
SHANK3 deficiency andASDbehavioral features (Boccuto et al.,
2013).
Recently, much experimental evidence has demonstrated
that zebrafish (Danio rerio) is a valuable model organism to
model human brain disorders, normal and pathological social
phenotypes and other ASD-like symptoms. In particular,
zebrafish can be used to explore the genetic or pharmacolog-
ical modulation of those diseases (Gerlai, 2010; Kalueff et al.,
2013; Stewart et al., 2013; Stewart et al., 2014), making
zebrafish a strong potential model organism for studying
ASD gene function early in development (Pather and Gerlai,
2009; Gerlai, 2010; Gerlai, 2011; Stewart et al., 2013).
SHANK3 appears only once in the human genome.
Nevertheless, this gene is duplicated in zebrafish, appearing
as shank3a (chromosome 18) and shank3b (chromosome 4)
(Kozol et al., 2015). Further examination of shank3a and
shank3b, as well as their different variants, will make a valu-
able contribution to the study of the function of human
SHANK3.
Five intragenic promoters (Wang et al., 2011; Jiang and
Ehlers, 2013; Zhu et al., 2014) and extensive alternative splice
variants have been identified in mouse and human SHANK3
(Lim et al., 1999; Wilson et al., 2003; Durand et al., 2007),
which all contribute to the diversity of Shank3 transcripts.
Moreover, Shank3 transcripts exhibit dynamic spatiotemporal
domains during the developmental stage when neural segment
regions are molded (Wang et al., 2014). The complexity of
Shank3 transcriptional regulation has been reported in mouse
(Jiang and Ehlers, 2013; Wang et al., 2014; Zhu et al., 2014).
Therefore, the clinical heterogeneity in the disorders caused
by SHANK3mutations may be due to the differential effects of
the variable locations of mutations within the coding exon of
each SHANK3 isoform.
A recent study has determined the developmental expres-
sion patterns of shank3a and shank3b in zebrafish, ranging in
the age from 2 to 120 hpf, and two transcripts of shank3 gene
have been verified and characterized (Kozol et al., 2015).
However, six shank3 transcripts exist according to the
Ensembl database (Zv9). It is urgent to further study the de-
velopmental expression of all shank3 transcripts in zebrafish
during more developmental stages, so as to improve the ex-
pression profile characteristics. Examining and analyzing the
profiles of these shank3 transcripts may provide a foundation
for the further establishment of a transgenic zebrafish model
of shank3.
Epigenetic modifications, resulting from enzymes such as
histone deacetylase (HDAC), have been shown to regulate the
expression and alternative splicing of neuronal genes (Schor
et al., 2009; Fischer et al., 2010). VPA is a typical example of
HDAC inhibitor that was recently found to have teratogenic
(interfering with early development) and neuropsychiatric
side effects related to in utero exposure (Jacob et al., 2014).
Moreover, fetal VPA exposure has been associated with a 3- to
46-fold increased risk of ASD (Dufour-Rainfray et al., 2010;
Bromley et al., 2013; Christensen et al., 2013; Wood, 2014).
Therefore, in this study, VPA was applied to investigate the
alterations of the expression levels of the different shank3
transcripts and to dissect the distinct functions of each con-
served domain.
In general, examination of the transcriptional and develop-
mental expression patterns as well as the differential effects on
zebrafish shank3 transcripts in response to VPA treatment is
crucial to establish a shank3-knockout zebrafish model for
elucidating the functions of each shank3 isoform and explor-
ing the mechanisms underlying ASD clinical heterogeneity.
Materials and methods
Fish and embryo maintenance
Wild-type zebrafish (Tu) were raised and maintained under
standard laboratory conditions at 28.5 °C in Bsystem water^
under a 14 h light/10 h dark cycle (Kalueff et al., 2014).
Freshly fertilized eggs were collected from multiple breeding
tanks containing 25 females and 25 males.
Evolutionary comparison and verification of six zebrafish
shank3 transcripts
The zebrafish shank3 nucleotide sequence, exon-intron struc-
ture, amino acid sequence, different transcripts and conserved
domains were analyzed using the NCBI gene database
(http://www.ncbi.nlm.nih.gov/gene/) and zebrafish whole
genome sequence project database (http://www.ensembl.
org/Danio_rerio). Protein sequences belonging to the shank3
family were identified using the NCBI BLAST program and
confirmed by best reciprocal BLAST.
In particular, since the 5′ open reading frame (ORF) of
shank3a-1 was incomplete, PCR amplification was then per-
formed on cDNA from 3-month-old zebrafish with primers de-
signed based on conservative regions of the predicted ORF se-
quence (forward: 5′-GAGAGTGTATGCATGAGGGAGGCAC-
3′ and reverse: 5′-GGTCTGGGTCTCCATATACAGTACCCC-
3′, Supplementary Material, Fig. S1). The PCR conditions were
as follows: 95 °C for 2 min, 35 cycles of 95 °C for 30 s, 56 °C for
30 s, 72 °C for 4min 10s, and a final extension at 72 °C for 5min.
The PCR products were then cloned into a pGEM-T Easy vector
(Promega) and sequenced.
To analyze SHANK3 gene evolution and conservation,
multiple alignments were performed and phylogenetic trees
constructed using MEGA 6. The alignments were imported
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into the BoxShade Server (http://www.ch.embnet.
org/software/BOX_form.html) to identify regions of high
local similarity.
Based on the sequences in the Ensembl database,
transcript-specific oligonucleotide primers and amplicons
were generated (Supplementary Material, Fig. S1 and
Table S1). cDNA from 3-month-old zebrafish was used as a
template for PCR, as noted above each 2 % agarose gel in
Fig. 2b.
Spatial expression pattern of larval zebrafish shank3a
and shank3b detected by whole-mount in situ
hybridization
Larvae were dechorionated and placed in a mixture of fish
facility system water and 0.003 % phenylthiourea at 24 hpf.
Embryos were fixed and processed for WISH. Table S2 in the
Supplementary Material lists the WISH primers that were
used to amplify and synthesize RNA probes. The PCR prod-
ucts were then cloned into a pGEM-T Easy vector. Sense and
antisense RNA probes were individually transcribed using
linearized constructs with T7 or Sp6 polymerase (Ambion,
USA) in the presence of digoxigenin (DIG, Roche,
Germany)-labeled UTP using a DIG-RNA Labeling Kit
(Roche, Germany). The resulting DIG-labeled antisense
probes were used to label the shank3a and shank3b genes re-
spectively, and the sense probes were used as negative con-
trols. WISH (approximately 40 eggs/clutch) was performed as
described previously (Thisse and Thisse, 2008) using 5-nitro-
blue tetrazoliumchloride and bromo-4-chloro-3′-indolyl phos-
phate p-toluidine salt (NBT/BCIP, Vector Laboratories) as
substrates (Thisse and Thisse, 2008). After WISH, the embry-
os were mounted in 4 % methylcellulose, and images were
captured using a Leica 205C microscope.
VPA treatments and phenotypic assessments
Embryos were dechorionated prior to drug treatment.
Zebrafish embryos were exposed to a final concentration of
0.5 or 1.0 mM VPA (P4543-10G, Sigma, USA) or a control
solution (0.3X Danieau’s solution), which was administered
continuously from 24 hpf until 48 hpf.
Embryos exposed to VPA or the control solution were ob-
served for morphological abnormalities at 48 hpf. The embry-
os were scored individually for several phenotypes, including
developmental retardation, pericardial effusion, spinal curva-
ture and reduced pigmentation. Each treatment consisted of
three biological replicates with 70 embryos per replicate.
During drug treatment, VPA-exposed and control zebrafish
embryos were observed under a microscope for any morpho-
logic abnormalities. The data were presented as the percent-
ages of embryos with each defect, and the results were calcu-
lated by dividing the total number of embryos with the
deformity by the total number of embryos in each replicate.
Samples were collected at 48 hpf and stored at −80 °C until
RNA isolation.
Quantitative real-time PCR
Approximately 20 zebrafish embryos at 1, 3, 5, 7, 10, 13, 15, 30,
and 60 days post-fertilization (dpf) were used for each condition,
and each experiment was performed in triplicate. Total RNAwas
extracted from the embryos using TRIzol reagent (Ambion,
USA). Extracted RNA was treated with DNase (Life
Technologies, USA) according to the manufacturer’s protocol.
Whole RNA samples were run on 2 % agarose gels to determine
RNA integrity. Reverse transcription was performed with a
PrimeScript™ RT Reagent Kit (TaKaRa, Japan). q-PCR was
performed using a LightCycler® 480 Instrument (Roche,
Germany) and SuperReal PreMix Plus (TIANGEN, China) ac-
cording to themanufacturer’s recommendations. The q-PCR con-
ditions were as follows: an initial cycle of 95 °C for 15 min;
40 cycles of 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 15 s;
and a final cycle of 95 °C for 1 min; followed by 40 °C for 1 min,
65 °C for 1 min, 95 °C for 1 min; and finally 40 °C for 1 min. As
an internal control, a 102-bp sequence of β-actin cDNA was
amplified by q-PCR using two specific primers (Supplementary
Material, Table S1). The primers used in this study were designed
using Primer3 and by running BLAT (https://genome.ucsc.
edu/cgi-bin/hgBlat) against the zebrafish genome to confirm
gene specificity and they are listed in Table S1 in the
Supplementary Material (Rozen and Skaletsky, 2000). The se-
quences of the newly identified splice variants were annotated
and deposited into the Ensembl database.
Results
shank3 is a conserved gene in the vertebrate lineage that
possesses multiple transcripts
The 5′ incomplete fragment of shank3a-1 (Supplementary
Material, Fig. S1) was isolated by PCR using specific primers
designed to acquire the full length of the ORF. As verified by
PCR and Sanger sequence analysis, shank3a-1 was termed as
the completed-length cDNA and has been studied in depth in
our study.
According to the NCBI BLAST Alignment results
(http://blast.ncbi.nlm.nih.gov/), the longest shank3a
(shank3a-1, our study) and shank3b (shank3b-1) protein
sequences of Danio rerio (Fig. 1a) exhibit a high level
of amino acid identity (55 and 59 %, respectively) with
the corresponding Homo sapiens SHANK3 protein
(NP_277052.1). In particular, the four typical conserved
domains (ANK, SH3, PDZ, and SAM domain) of
shank3 exhibit at least 80 % amino acid identity
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(Supplementary Material, Fig. S2). These findings indi-
cate that human SHANK3 is highly conserved in
zebrafish and that zebrafish might be a strong potential
model for studying human SHANK3.
To further examine the orthologs between zebrafish
shank3 and other species, we performed phylogenetic
analysis to compare shank3 of Danio rerio with that of
Homo sapiens and 11 other species by constructing a
phylogenetic tree (Fig. 2a). The obtained numbers repre-
sented evolutionary relationships, with larger numbers in-
dicating greater genetic differences. In vertebrate animals,
the genetic distance was not greater than B0.3^; however,
in invertebrates (such as Bactrocera cucurbitae), the dis-
tance was as high as B1.5^ (Fig. 2a). Therefore, this phy-
logenetic analysis revealed a highly conserved pattern in
mammals, rodents, and other vertebrates, implying that
shank3 is unique to the vertebrate lineage.
However, the alternative splicing of shank3 in zebrafish
has not been fully characterized (Gauthier et al., 2010).
Based on the sequences in the Ensembl database, each tran-
script of zebrafish shank3 has some unique sequences that are
either in the exon or intron of other transcripts. We were able
to generate transcript-specific oligonucleotide primers and
amplicons to confirm the existence of shank3 splice variants
(Supplementary Material, Fig. S1). The amplification results
confirmed that the key sequences of the six zebrafish shank3
transcripts did exist (Fig. 2b).
Spatial and temporal expressions of shank3 in zebrafish
To determine the spatial and temporal expression pat-
terns of shank3a and shank3b in zebrafish, we chose
the longest zebrafish shank3a transcript (shank3a-1)
and shank3b transcript (shank3b-1) to perform the
whole mount in situ hybridization at 2, 10, 14, 24, 48,
and 72 hpf. We found that both of them exhibited a
specific pattern of concentrated expression in the
zebrafish larval brain. At early ages (before 24 hpf,
Fig. 1 Multiple transcripts of
shank3 in zebrafish. a The
structures of six zebrafish shank3
transcripts are shown. Yellow
rectangles indicate the 5′ and 3′
UTRs. Notably, the SHANK3
gene is duplicated in zebrafish,
appearing as shank3b
(chromosome 4) and shank3a
(chromosome 18). b Extensive
predicted protein isoforms of
zebrafish shank3. The protein
domains are shown and aligned to
corresponding exons (ANK
ankyrin repeat domain, SH3 Src
homology 3 domain, PDZ PSD-
95/discs large/ZO-1 domain, SAM
sterile alpha motif domain
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Fig. 3a–c, j–l), both shank3a and shank3b were barely
expressed, whereas their expression levels increased af-
ter 24 hpf (Fig. 3d–i, m–r) and tended to increase
throughout development in zebrafish larvae. In addition,
the expression levels of shank3a and shank3b on 24 hpf
were similar, whereas on 48 and 72 hpf, shank3a
displayed a higher expression level than shank3b.
Moreover, the expressions of both of these isoforms
were mainly concentrated in the nervous system of
zebrafish larvae, particularly in the anterior-ventral
forebrain.
To further distinguish the different developmental
profiles of each shank3 isoform, isoform-specific q-
PCR was performed using whole brains from wild-type
zebrafish on nine different developmental stages
(Fig. 4g). Remarkably, the expression of all zebrafish
shank3 transcripts gradually increased over the first
7 dpf (Fig. 4g, a–f). The most obvious increasing trend
in shank3 expression was observed from 3 to 7 dpf,
correlating with the WISH expression pattern and the
time frame for synaptogenesis. A peak in shank3 ex-
pression was observed on approximately 7 dpf.
Fig. 2 Phylogenetic tree of evolutionary relationship of SHANK3
proteins. a Diverse animal phyla were identified by a best reciprocal
BLAST search with human SHANK3 and are mapped onto a
phylogenetic tree. All of the sequences are available from the NCBI
protein database with the exception of zebrafish shank3a, which was
obtained from the Ensemble protein database and our study. Homo
sapiens (NP_277052.1), Pongo abelii (XP_009232827.1), Rattus
norvegicus (NP_067708.1), Mus musculus (NP_067398.2), Bos Taurus
(XP_010804153.1), Taeniopygia guttata (XP_012432256.1), Xenopus
(Silurana) tropicalis (XP_002941881.2), Danio rerio shank3b (XP_
001919745.1), Bactrocera cucurbitae (XP_011184638.1), Pteropus
vampyrus (XP_011382480.1), Takifugu rubripes (XP_003967184.1),
Anolis carolinensis (XP_008121382.1), Haliaeetus leucocephalus (XP_
010564365.1), and Danio rerio shank3a (ENSDART00000139505 and
our study). The tree was constructed using the neighbor-joining methods
as implemented in theMEGA 6 package. Clade robustness was measured
by the bootstrap method with 1000 replicates. The lengths of the lines are
proportional to the evolutionary distances from branching points. b
Transcript-specific oligonucleotide primers and amplicons were
generated to confirm the existence of the key fragment of six predicted
transcripts of shank3 in the Ensembl database. cDNA from 3-month-old
zebrafish was used as a template for PCR, as noted above each 2 %
agarose gel. The housekeeping gene β-actin was used as an internal
reference
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Notably, all of the shank3 transcripts displayed a grad-
ual decrease in expression after 7 dpf, and their expres-
sion levels, with the exception of that of shank3b-2
(Fig. 4b), decreased by at least 50 % compared with
the peak point by 15 dpf. In addition, these transcripts
displayed a second increasing peak between 1 mpf and
adulthood. The expression levels of shank3b-1 (Fig. 4a),
shank3a-1 (Fig. 4c) and shank3a-3 (Fig. 4e) markedly
increased from 5 to 7 dpf. In contrast, the shank3b-2
(Fig. 4b) and shank3a-4 (Fig. 4f) expression levels were
relatively stable before adulthood.
Isoform-specific expression pattern of shank3
during development
To perform an in-depth analysis of the differential ex-
pression of each isoform at the same age stage, the
isoform-specific expression of zebrafish shank3 was
then examined (Fig. 5). The expression levels of
shank3b transcripts (shank3b-1 and shank3b-2) were
low throughout development; whereas all shank3a tran-
scripts (shank3a-1, shank3a-2, shank3a-3 and shank3a-
4) displayed relatively higher expression levels. On
1 dpf, all of the transcripts showed relatively lower
expression levels (Fig. 5a). However, during the period
from 3 to 10 dpf (Fig. 5b–e), the expression levels of
all shank3a transcripts were obviously higher than that
of shank3b, which is consistent with the WISH results
(see above). Moreover, the difference between shank3b-
1 and shank3b-2 was not significant from 1 to 5 dpf
(Fig. 5a–c), whereas after 7 dpf, the expression of
shank3b-1 was higher than that of shank3b-2.
The ANK and SAM domains of zebrafish shank3 may
display the opposite effect following treatment with VPA
To examine whether different shank3 transcripts were subject
to HDAC, zebrafish embryos were treated with VPA. The
concentrations that caused teratogenic effects, as detailed in
the literature, varied among studies but generally ranged from
0.1 to 3.0 mM (Li et al., 2009; Selderslaghs et al., 2009;
Brannen et al., 2010; Terbach et al., 2011; Cowden et al.,
2012; Teixido et al., 2013). Thus, an initial dose-response
experiment was conducted to determine the effects of two
different VPA concentrations, 1 and 0.5 mM, on zebrafish
embryos (Fig. 6). The VPA-treated zebrafish embryos
displayed numerous morphological abnormalities, and those
exposed to a higher concentration displayedmore deformities.
Most embryos exposed to 1 mM VPA exhibited phenotypic
abnormalities, including developmental retardation (100 %,
70/70), reduced pigmentation (100%, 70/70), spinal curvature
(43 %, 30/70) and pericardial effusion (64 %, 45/70,
Supplementary Material, Figs. S3A and B). Additionally, em-
bryos that exposed to 0.5 mMVPA displayed relatively fewer
defects, such as developmental retardation (100 %, 70/70),
reduced pigmentation (83 %, 58/70), spinal curvature (20 %,
14/70) and pericardial effusion (40 %, 28/70, Supplementary
Material, Figs. S3C and D).
Notably, the VPA treatment exhibited varying effects on
different shank3 transcripts. In the zebrafish embryos treated
with 1 mM VPA, the expressions of all transcripts containing
the SAM domain (shank3b-1, shank3a-1and shank3a-4,
Fig. 1b) were significantly increased (Fig. 6a), whereas of
the expressions of shank3b-2 and shank3a-3 (Fig. 1b), which
contained an ANK domain but without the SAM domain,
were remarkably decreased (Fig. 6a). The opposite direction
Fig. 3 Analysis of region-
specific expression of shank3a
and shank3b in wild-type
zebrafish by WISH. a–iWISH
analysis of the level and pattern of
shank3a and shank3b expressions
at 2, 10, 14, 24, 48, and 72 hpf
were showed. The black arrow
heads in d–i and m–r show the
expression signals in the zebrafish
larva brain. Obviously, the
expression of both of these
isoformswasmainly concentrated
in the nervous system of zebrafish
larvae, particularly in the anterior-
ventral forebrain
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was also replicated in lower VPA concentrations (0.5 mM,
Fig. 6b). In summary, our data suggest that the ANK and
SAM domains of shank3 are more susceptible to VPA and
are crucial for the normal function of shank3.
Fig. 4 Differential expression of
zebrafish shank3 transcripts
throughout development. a–g The
expression of six shank3
transcripts of zebrafish from 1 day
to 3 months post-fertilization was
determined by q-PCR. The
crossing point (CP) values of each
transcript were normalized to that
of a housekeeping gene, β-actin.
The error bars denote the stan-
dard deviations from three RNA
sample replicates for each devel-
opmental time point. All data are
shown as the means ± SEM
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Fig. 5 Isoform-specific pattern during the same period. a–i Comparisons
of the expression patterns of six different shank3 isoforms in the zebrafish
brain at the same stage are shown. The crossing point (CP) values of each
isoform were normalized to that of a housekeeping gene, β-actin. The
error bars denote the standard deviations from three RNA sample
replicates for each developmental time point. All data are shown as the
means ± SEM
Fig. 6 Isoform-specific expression of zebrafish shank3 induced by VPA
compared with the control. a, b q-PCR analysis of zebrafish shank3
transcripts at 48 hpf after treatment with 1 or 0.5 mM VPA for 24 h. All
data are shown as the means ± SEM. The statistical significance values,
such as *P < 0.1, **P < 0.01, and ***P < 0.005, of differences compared
with the control groupwere determined through two-tailed t test (n = 15 in
each group)
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Discussion
Our study demonstrated that zebrafish shank3 was unique
to the vertebrate lineage (Fig. 2a) and possessed an
ortholog of human SHANK3 that has retained the con-
served ANK, SH3, PDZ and SAM domains (Supple
mentary Material, Fig. S2). Comprehensive and systemat-
ic experiments were performed to analyze the isoform-
specific expression of shank3, which displayed temporal
and spatial specific patterns. In particular, VPA could reg-
ulate the expression of shank3 in zebrafish, and shank3
transcripts containing a SAM domain displayed signifi-
cantly decreased expression patterns, whereas those con-
taining an ANK domain but without the SAM domain
showed the opposite trend, supporting the hypothesis that
each isoform has distinct functions because of the differ-
ent features of each domain.
Taken together, these findings will enhance the current
knowledge of the molecular diversity in the brain and provide
insights into the phenotypic heterogeneity caused by various
SHANK3 defects in humans.
The expression profiles of shank3 may be linked
with synaptic development
Shank3 expression has been widely characterized in mamma-
lian animal models (Jiang and Ehlers, 2013; Wang et al.,
2014), and the spatial expression patterns of shank3a and
shank3b at 48 hpf in zebrafish have also been determined
(Kozol et al., 2015). On the basis of previous research, we
further validated the expression patterns of more developmen-
tal stages. The results revealed that zebrafish shank3 was
mainly expressed in the nervous system, particularly in the
anterior-ventral forebrain (Fig. 3d–i, m–r). Over the first
3 days, almost all shank3 transcripts displayed a low level of
expression (Fig. 4g); thereafter, a rapid increase in expression
that corresponded with the time frame for synaptogenesis was
observed. As a scaffolding protein, shank3 played a key role
in synaptic formation, maturation, maintenance, and transmis-
sion. The increasing expression over the first several days
corresponded with the rapid development of the nervous sys-
tem, which indirectly reflected the increasing head circumfer-
ences in children with age. The increase in brain size over time
was due to the early growth of gray matter followed by the
pruning of dendrites and synaptic structures, combined with
major growth of white matter as it underwent myelination
(Geschwind and Levitt, 2007). Shaw et al. (Shaw et al.,
2006) suggested that cognitive skills were more significantly
correlated with the developmental trajectory of brain volumes
over time than with static brain volume.
Our results also demonstrated that the expressions
of shank3 transcripts declined afterward, which large-
ly coincided with the data obtained from mouse
studies (Wang et al., 2014). Wang et al. examined
the developmental expression of five Shank3 tran-
scripts in mouse brains with different ages and ob-
served a peak of expression that occurred between 2
and 4 weeks. However, in our results, the first peak
was observed on approximately 7 dpf and the second
peak was detected during adulthood. In addition, in
mouse studies (Wang et al., 2014), two transcripts
(Shank3a and Shank3b) displayed similar trends to
those of shank3b-1 and shank3b-2, respectively, in
our study. Interestingly, in-depth investigations into
the protein structures revealed that these mouse and
zebrafish transcripts share the same conserved do-
mains. The other four shank3 transcripts (shank3a-1,
shank3a-2, shank3a-3 and shank3a-4) in zebrafish
differed from those in the mouse, which may reflect
functional differences. Therefore, a more thorough
analysis of these different transcripts would compen-
sate for insufficiencies in mouse models.
Two recent studies have analyzed the shank3 gene in zebrafish
(Gauthier et al., 2010; Kozol et al., 2015). Both studies used
morpholinos to knock down the expression of shank3a and
shank3b (Kozol et al., 2015) or zs3.1 and zs3.2 (Gauthier et al.,
2010), systematically clarifying the functions of the two shank3
transcripts. Upon performing a BLASTsearch of the morpholino
oligonucleotides used in their studies (Supplementary Material,
Fig. S4), we found that shank3a (Kozol et al., 2015) corresponded
to shank3a-1 and shank3a-3 in our study and that shank3b (Kozol
et al., 2015) corresponded to shank3b-1 and shank3b-2. Thus,
only some of the shank3 transcripts were likely knocked down,
whereas the others remained unaffected. Furthermore, in the study
of Gauthier et al., only four transcripts (shank3b-1, shank3b-2,
shank3a-1 and shank3a-2) were knocked down (Gauthier et al.,
2010). A further study of the functions of the remaining tran-
scripts is warranted. In addition, the studies of these transcripts
are currently underway in our laboratory.
Parenthetically, each shank3 isoformhas a unique combination
of protein domains. Full-length shank3a-1and shank3b-1 contain
all four domains (ANK, SH3, PDZ, and SAM), which allow for
their interactions with all possible interacting proteins. Other iso-
forms with different combinations of functional domains interact
with different subsets of synaptic proteins. For instance, the C-
terminal truncated shank3a-3 (Fig. 1b) can only interact with α-
fodrin but not with mGluRs, Homer1 or other partners. Because
each protein domain mediates a unique complement of protein-
protein interactions (Hayashi et al., 2009), each shank3 isoform
likely has distinct functions.
Taken together, these results provide evidence to sup-
port the findings that different shank3 isoforms have dis-
tinct functions at synapses and are associated with different
clinical presentations. However, the exact mechanism reg-
ulating shank3 transcription in zebrafish remains to be in-
vestigated in the future.
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The SAM and ANK domains may be a key connection
between shank3 and VPA
The epigenetic modification of DNA by the methylation of
cytosine in CpG dinucleotides and histone modification rep-
resented a common mechanism to regulate the gene expres-
sion (Collas, 1998). VPA is a known HDAC inhibitor that
could activate genes through reprogramming of genome ex-
pression and by causing hyperacetylation of induced genes
(Milutinovic et al., 2006).
In this study, we demonstrated that VPA treatment altered
shank3 mRNA expression during zebrafish development. To
the best of our knowledge, this is the first study evaluating the
effects of VPA on shank3 transcript expression in zebrafish.
Treatment with VPA during embryonic development induced
a delayed development in hatching and an increased number
of malformations. The toxic responses to VPA (1 and 0.5 mM)
were dose-dependent (Terbach et al., 2011).
Notably, the expression levels of shank3b-1, shank3a-1
and shank3a-4 significantly increased after treatment with
1 mM VPA (Fig. 6a). Further analyses of their protein struc-
tures revealed that the three transcripts all contained a SAM
domain (Fig. 1b). The SAM domain was next to the C termi-
nus of shank3 and these proteins bound to each other in a
homomeric and heteromeric manner, indicating that shank3
proteins could multimerize in a tail-to-tail manner (Sheng
and Kim, 2000).
Another interesting finding was that the expression
levels of shank3b-2 and shank3a-3, which lacked the
SAM domain but contained the ANK domain, were mark-
edly decreased after exposure to both 1 and 0.5 mM VPA
(Fig. 6a). However, full length shank3a-1 and shank3b-1
isoforms that encoded all protein interaction domains
exhibited the reverse effect. One possible explanation
was that the SAM domain likely offsetted the increasing
effect. The ANK domain associated with the actin-based
cytoskeleton and was conducive to dendritic spine
development (Lim et al., 1999; Jiang and Ehlers, 2013).
α-Fodrin has been shown to interact with the N-terminal
ANK repeats of shank3 (Bockers et al., 2001). In addition,
ANK repeats exhibited secondary structures in the form of
pairs of anti-parallel α-helices that were linked by a variety
of β-hairpin motifs. However, these repeats did not prefer
specific motifs, nor did they recognize consensus
sequences of the target molecules (Sedgwick and
Smerdon, 1999; Bockers et al., 2001).
Shank3 contains multiple domains for protein-protein
interactions, but understanding of their functional signif-
icance for each domain is lacking (Sheng and Kim,
2000). Our results suggested that VPA selectively al-
tered the expression of shank3 transcripts containing
the SAM and ANK domains and implied a functional
correlation for the Shank3 proteins with these domains.
The complexity of the shank3 transcript structure indicates that
the point mutations, translocations, and intragenic deletions of
shank3 observed in ASD patients are isoform-specific (Jiang
and Ehlers, 2013). Further studies are necessary to determine
the functions of each isoform in vivo and their relevance to syn-
aptic and behavioral phenotypes. Understanding the unique func-
tion of each shank3 transcript will undoubtedly be beneficial for
future drug screening.
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